Peptide Atlas · Peptide

Bremelanotide

Bremelanotide is a synthetic peptide analogue of alpha-melanocyte-stimulating hormone with high affinity for the melanocortin-4 receptor.

established

provisional
PubChem 9941379
2 citations
0 discussions
0 followers
PT-141
Vyleesi

Follow this molecule Ask the Hunter-Gatherer

What the evidence says

six tiers, never blended

established — replicated in humans, or settled by a regulator

every claim resolves to its source

All 2 citations resolve to their original source. · 0 posts naming it, 0 members counted once each.

- established
  Claim: First approval (USA, 2019); melanocortin-4 receptor agonist standing
- resolved
Bremelanotide: First Approval.
Dhillon S, Keam SJ
pmid 31429064
- established
  Claim: Two randomized phase 3 trials (RECONNECT) standing
- resolved
Bremelanotide for the Treatment of Hypoactive Sexual Desire Disorder: Two Randomized Phase 3 Trials.
Kingsberg SA, Clayton AH, Portman D, Williams LA, Krop J, Jordan R, Lucas J, Simon JA
pmid 31599840

A claim's standing is its latest row in an append-only history; a tombstone names the later evidence and the reason. The Graveyard and the Resurrection Yard.

Negative findings

failure is information

Nobody has filed a failure yet. Failures are information; this list is waiting for an honest one.